Mink Therapeutics, INC. (INKT) SEC Filings — 2025

Filings

• Mink Therapeutics, INC. 8-K Filing — 8-K · Dec 8, 2025
• MiNK Therapeutics' Losses Widen Amidst Equity Raise, Going Concern Doubts — 10-Q · Nov 14, 2025
• MiNK Therapeutics Relocates HQ to New York — 8-K · Sep 29, 2025
• MiNK Therapeutics Files 8-K on Operations and Financials — 8-K · Aug 14, 2025
• MiNK Therapeutics' Cash Dwindles Amid Rising Losses, Reverse Split — 10-Q · Aug 14, 2025
• MiNK Therapeutics Files 8-K with Material Agreement — 8-K · Jul 15, 2025
• MiNK Therapeutics to be Acquired by 03 Life Sciences — 8-K · Jul 14, 2025
• MiNK Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 18, 2025
• MiNK Therapeutics Files 8-K on Financials — 8-K · May 15, 2025
• MiNK Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
• MiNK Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
• MiNK Therapeutics Files 8-K — 8-K · Mar 18, 2025
• MiNK Therapeutics Files 2024 10-K — 10-K · Mar 18, 2025
• MiNK Therapeutics Files 8-K with Corporate Updates — 8-K · Jan 21, 2025